article thumbnail

MSD receives FDA approval for Enflonsia to prevent RSV

Pharmaceutical Technology

MSD research laboratories president Dean Li stated: “Enflonsia provides an important new preventive option to help protect healthy and at-risk infants born during or entering their first RSV season with the same dose regardless of weight. Give your business an edge with our leading industry insights.

article thumbnail

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

Pharmaceutical Technology

MSD Research Laboratories global clinical development senior vice-president and head, chief medical officer Dr Eliav Barr stated: “MSD has been at the forefront of HIV research for more than 35 years and we are pleased to continue our work to innovate and deliver new options that aim to meet the needs of the HIV community.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA approves MSD’s Keytruda to treat head and neck cancer

Pharmaceutical Technology

GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

article thumbnail

STAT+: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’

STAT

Glimcher, chief executive of Dana-Farber Cancer Institute, said she would step down next month, ending an eight-year run capped by her  surprise split  with Dana-Farber’s longtime partner, Brigham and Women’s Hospital, and decision to build a cancer center with Beth Israel Deaconess Medical Center. Benjamin L.

article thumbnail

Empowering Women: 5 Compelling Reasons Women Pursue a Career in Pharmacy

Pharmacy Is Right For Me

Pharmacists can work in a variety of settings, including hospitals, community pharmacies, research laboratories, and government agencies. For example, they can become clinical pharmacists and work in hospitals. They can also become researchers, educators, or consultants.

article thumbnail

Teva appoints Eric Hughes as head of R&D and Chief Medical Officer

European Pharmaceutical Review

He then had a one-year stint at Merck Research Laboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. Dr Hughes earned his MD and PhD at Yale School of Medicine.

article thumbnail

ICR and Royal Marsden NHS Foundation Trust open new integrated pathology unit

Pharmaceutical Technology

The Institute of Cancer Research (ICR), along with its hospital partner The Royal Marsden NHS Foundation Trust, has opened a new joint integrated pathology unit (IPU). The IPU will support clinical trial research and will employ new technology to diagnose cancer in a faster and less expensive way.